Gregory Martin, MD
Pulmonary Disease · Atlanta, GANPI 1639180995
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $80,418 of the $87,984 with a category attached, or 91.4%. 7 manufacturers reported payments, led by Regeneron at 39.8% of the total. Reporting peaked in 2019 at $56,065 and has fallen 93.8% since, to $3,489 in 2025. Among pulmonary disease clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $3258.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$35K
- Grifols Shared Services North America, Inc.$21K
- Beckman Coulter, Inc.$15K
- Grifols, S.A.$13K
- C. R. Bard, Inc. & Subsidiaries$3K
- Partner Therapeutics, Inc.$450
- plus $32 from 1 others
What the payments were for
- Consulting fees$80,41891%
- Speaking & faculty fees$6,4897%
- Travel & lodging$9181%
- Food & beverage$1580%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 1 | $35,000 |
| Grifols Shared Services North America, Inc. | 7 | $20,709 |
| Beckman Coulter, Inc. | 12 | $15,185 |
| Grifols, S.A. | 4 | $13,307 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $3,300 |
| Partner Therapeutics, Inc. | 1 | $450 |
| Baxter Healthcare | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$87,984 in reported general payments places this provider in the 95th percentile of 365 pulmonary disease providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Atlanta
- Colin SwensonAtlanta$255K
- Eric FlenaughAtlanta$93K
- Victor TsengAtlanta$55K
- Ralitza MartinAtlanta$48K
- Venkatesh LakshminarayananAtlanta$33K
- Sisir AkkineniAtlanta$21K
- Gerald StatonAtlanta$21K
- Mirza AliAtlanta$16K
- Srihari VeeraraghavanAtlanta$16K
- Lawrence McDermottSavannah$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.